New York Times, July 6, 2017
Roni Caryn Rabin


Read the Full Article

A leading academic medical center in New York City has offered to treat Charlie Gard, an 11-month-old infant in Britain who was born with a rare and fatal genetic disease.

European courts have ruled that he should be taken off life support, as there are no effective treatments for his condition. His parents were denied permission to bring him to the United States for experimental therapy.

The court decisions captured the attention of Pope Francis and President Trump, who tweeted on Monday that if the United States could help, “we would be delighted to do so.”

In a statement issued Thursday by NewYork-Presbyterian Hospital/Columbia University Medical Center, officials agreed to admit Charlie as an inpatient as long as he can be transferred safely and there are no legal or regulatory barriers to treating him with an experimental medication. [...]

bioethics health law policy international